ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Down 8.7% in September

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) was the target of a large drop in short interest in September. As of September 30th, there was short interest totalling 8,400 shares, a drop of 8.7% from the September 15th total of 9,200 shares. Based on an average trading volume of 13,900 shares, the short-interest ratio is presently 0.6 days.

ProShares Ultra Nasdaq Biotechnology Stock Up 0.2 %

Shares of BIB stock traded up $0.15 during trading on Thursday, reaching $65.81. The company had a trading volume of 1,440 shares, compared to its average volume of 24,713. The firm’s 50 day simple moving average is $64.57 and its two-hundred day simple moving average is $60.20. ProShares Ultra Nasdaq Biotechnology has a one year low of $40.10 and a one year high of $69.56.

ProShares Ultra Nasdaq Biotechnology Increases Dividend

The business also recently disclosed a dividend, which was paid on Wednesday, October 2nd. Investors of record on Wednesday, September 25th were paid a $0.1528 dividend. This is an increase from ProShares Ultra Nasdaq Biotechnology’s previous dividend of $0.04. The ex-dividend date was Wednesday, September 25th.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in BIB. Toth Financial Advisory Corp increased its position in ProShares Ultra Nasdaq Biotechnology by 132.3% in the 1st quarter. Toth Financial Advisory Corp now owns 26,111 shares of the exchange traded fund’s stock worth $1,502,000 after buying an additional 14,870 shares during the period. Westwood Wealth Management bought a new position in ProShares Ultra Nasdaq Biotechnology in the 1st quarter worth approximately $575,000. Finally, Texas Capital Bank Wealth Management Services Inc bought a new position in ProShares Ultra Nasdaq Biotechnology in the 1st quarter worth approximately $288,000.

About ProShares Ultra Nasdaq Biotechnology

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.